The Global Generative AI In Chemical Market is expected to grow at a compound annual growth rate (CAGR) of 29.8% between 2025 ...

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights, and healthcare intelligence, ...

HALIFAX, NS / ACCESSWIRE / January 14, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today the approval from Health Canada for its Reveal®Rapid G4 HIV-1/2 Test (Reveal® ...

Joining forces to deliver customized automation and AI-driven revenue cycle management solutions, revolutionizing healthcare operations nationwide. OAK BROOK, ILLINOIS / ACCESSWIRE / January 14, 2025 ...

Complex veterinary procedure restores health and qualify of life, offering new hope to pet-parents facing complicated neurological disorders BEND, OREGON / ACCESSWIRE / January 14, 2025 / The ...

Domino Printing Sciences (Domino) is pleased to announce the launch of its new Mx-Series electric pallet labeller – the Mx350i-eP. The new, electrically driven pallet labeller boasts a suite of smart ...

The Columbia-based company drove over 1,000% Revenue Growth since 2021, driven by actuarially validated outcomes, New and Expanded Strategic Partnerships, and Industry Recognition COLUMBIA, MARYLAND / ...

Honoring a Quarter Century of Dedicated Support for Children with Autism and Their Families DALLAS, TEXAS / ACCESSWIRE / January 14, 2025 / For 25 years, Behavioral Innovations has been a beacon of ...

SIOUX FALLS, SD / ACCESSWIRE / January 14, 2025 / Avel eCare, the nation's leading telemedicine provider of clinician-to-clinician services, proudly announces a strategic partnership with Cibolo ...

Terumo Blood and Cell Technologies (Terumo BCT), and FUJIFILM Irvine Scientific have announced a strategic collaboration to help accelerate T cell expansion using Fujifilm's PRIME-XV® T Cell Expansion ...

One-year follow-up data confirm favorable safety profile of BellaSeno´s scaffolds compared to silicone implantsCompany plans expansion to primary breast augmentation and lumpectomyLeipzig, Germany/ ...

Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that the supplemental New Drug Application for ORPATHYS® (savolitinib) has been granted approval by the China National Medical Products ...